Weight Loss Drug Under Review

The Medicine and Healthcare Products Regulatory Authority (MHRA) is reviewing the weight loss drug Saxenda.

Concern has arisen due to reported suicidal thoughts from some patients. The EU have launched their own enquiry.

We have discussed this with one client who offers treatment with this drug as well as surgical options. This business routinely investigates the psychological profiles of patients and the clear advice is any practitioner seeking to make use of Saxenda does the same.

Psychological assessment is a vital part of assessing patients for any aesthetic treatment and all the more so if the use of Saxenda is planned.

We will report further as the results of the various reviews become known.